After a survival analysis, and drug–target–pathway analysis, five hub genes (HSP90AA1, ESR1, CYP3A4, CDK1, and MMP9) were discovered to be involved in the overall survival of LC patients. This evidence concerns the gene ESR1 and laryngotracheoesophageal cleft.